
Could Newly Approved Sleep Apnea Drug Let Some Ditch Their
Summary: Tirzepatide (Zepbound), a GLP-1 receptor agonist, has been FDA-approved for obstructive sleep apnea (OSA) in people with obesity, raising questions about whether it could help some patients reduce or eliminate the need for CPAP. While weight loss from the drug may improve airway function in weight-related OSA, experts caution that CPAP should not be…